FDA analysis: Impact of body mass index (BMI) on outcomes in relapsed-refractory multiple myeloma Meeting Abstract
| Authors: | Ershler, R.; Kanapuru, B.; Gong, Y.; Shah, U. A.; Mailankody, S.; Landgren, O.; Theoret, M.; Gormley, N. J.; Farrell, A. T.; Pazdur, R. |
| Abstract Title: | FDA analysis: Impact of body mass index (BMI) on outcomes in relapsed-refractory multiple myeloma |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164606223 |
| DOI: | 10.1182/blood-2019-130551 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5505 -- Source: Wos |
